MedPath

Randomized-controlled pilot trial to compare continuous wound infiltration with local anesthetics via elastomer pump versus epidural analgesia following elective upper abdominal surgery via midline laparotomy

Not Applicable
Conditions
R52
postoperative pain management
Pain, not elsewhere classified
Registration Number
DRKS00008023
Lead Sponsor
niversitätsklinikum Heidelberg
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
All
Target Recruitment
71
Inclusion Criteria

Elective upper abdominal surgery via a midline-laparotomy
- Indication for epidural analgesia
- Age = 18 years
- Written informed consent
- Ability of subject to understand the nature and consequences of the clinical trial

Exclusion Criteria

- Chronic pain and/or regular consumption of opioid analgesics
- Contraindication for thoracic epidural analgesia or epifascial continuous wound infiltration
- Inability to walk unaided and without adjuvants
- Planned stoma placement
- Hypersensitivity or allergy to one or more of the analgesic medications used in the trial
- Pregnancy or breast-feeding
- Participation in another intervention-trial with interference of intervention and outcome of this study

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1. Feasibility of assessing post-operative patient mobility with a pedometer<br>2. Feasibility of patient recruitment in the planned time frame<br>3. Evaluation of the comprehensive complication index (CCI) by examining the overall postoperative morbidity of patients in the study<br>4. Pain scores at rest and on movement 48 and 72 hours post-operatively according to the numeric rating scale (NRS)<br>5. Total amount of opioids administered during 0–24, 24–48 and 48-72 hours post-operatively<br>6. Time to first flatus/bowel movement<br>7. Body weight<br>8. Rate of treatment failure, defined as the need for the use of an intravenous patient-controlled analgesia PCA system<br>9. Rate of catheter-related complication<br>10. Rate of surgical side infection according to the definition of the Centre for Disease Control and Prevention (CDC)<br>11. Days of catheter-therapy <br>12. Length of hospital stay<br>13. Rate of serious adverse events (SAEs) in both groups.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath